A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity.

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity.

Show other versions (1)

Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present study aimed to establish a bioinformatics pipeline capable of defining and validating NAFLD biomarker candidates based on paired hepatic globa...

Full description

Bibliographic Details
Main Authors: Christoffer A Hagemann, Christian Legart, Mathias B Møllerhøj, Martin R Madsen, Henrik H Hansen, Merete J Kønig, Frederik Helgstrand, Flemming P Hjørne, Anders Toxværd, Jill L Langhoff, Urd L Kielgast, Lise L Gluud, Helene Ægidius, Kristoffer T G Rigbolt, Tina Vilsbøll, Jacob Jelsing, Filip K Knop
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0275901

Internet

https://doi.org/10.1371/journal.pone.0275901

Similar Items